Options
The methylisothiazolinone epidemic goes along with changing patients' characteristics – After cosmetics, industrial applications are the focus
Date Issued
2019
Author(s)
Schnuch, Axel
Schubert, Steffen
Lessmann, Holger
Geier, Johannes
Beiteke, Ulrike
Dissemond, Joachim
Schäkel, Knut
Pföhler, Claudia
Dietrich, Cecilia
Worm, Margitta
Bauer, Andrea
Kreft, Burkhard
Schliemann, Sibylle
Brockow, Knut
Becker, Detlef
Forchhammer, Stephan
Recke, Andreas
Witte, Jana
Pfützner, Wolfgang
Coras‐Stepanek, Brigitte
Skudlik, Christoph
Wagner, Nicola
Aberer, Werner
Baron, Jens Malte
Siedlecki, Katharina
Baur, Vera
Schmieder, Astrid
Weisshaar, Elke
Grunwald‐Delitz, Heidrun
Trautmann, Axel
Hofmeier, Kathrin Scherer
Szliska, Christiane
Weiß, Johannes
Effendy, Isaak
Jünger, Michael
Brehler, Randolf
Rueff, Franziska
Werfel, Thomas
Dickel, Heinrich
Rieker‐Schwienbacher, Juliane
Vieluf, Dieter
Stadler, Rudolf
Simon, Dagmar
Fartasch, Manigé
Micaletto, Sara
Treudler, Regina
Nestoris, Stefan
Mechtel, Dirk
Schröder‐Kraft, Claudia
Löffler, Harald
Gina, Michal
Koch, André
Raap, Ulrike
Grabbe, Jürgen
Spring, Philipp
Prager, Welf
Wilfinger, Daniel
DOI
10.1111/cod.v82.2